Upgrade to SI Premium - Free Trial

Protagonist Therapeutics (PTGX)

135.43 -0.01 (0.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Protagonist Therapeutics (PTGX) PT Raised to $155 at TD Cowen July 20, 2026 6:33 AM - StreetInsider Protagonist Therapeutics (PTGX) PT Raised to $165 at Citizens as Icotyde Revenue Ramps July 17, 2026 5:06 AM - StreetInsider Protagonist Therapeutics Reports Granting of Inducement Awards July 16, 2026 4:05 PM - StreetInsider Protagonist Therapeutics (PTGX) PT Raised to $151 at Barclays July 14, 2026 5:13 AM - StreetInsider Protagonist Therapeutics (PTGX) PT Raised to $145 at Truist Securities July 7, 2026 6:03 AM - StreetInsider Protagonist Therapeutics Reports Granting of Inducement Awards July 1, 2026 4:06 PM - StreetInsider TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX) July 1, 2026 9:13 AM - StreetInsider Form 4 Protagonist Therapeutics For: Jun 23 Filed by: Waddill William D. June 25, 2026 4:10 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: Waddill William D. June 23, 2026 4:27 PM - SEC Filing Form 8-K Protagonist Therapeutics For: Jun 17 June 18, 2026 4:31 PM - SEC Filing Protagonist Therapeutics Reports Granting of Inducement Awards June 16, 2026 4:01 PM - StreetInsider Form 4 Protagonist Therapeutics For: Jun 10 Filed by: Waddill William D. June 11, 2026 7:07 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: Waddill William D. June 10, 2026 4:30 PM - SEC Filing Form 4 Protagonist Therapeutics For: May 29 Filed by: Waddill William D. June 1, 2026 6:31 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: Waddill William D. May 29, 2026 4:23 PM - SEC Filing Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026 May 28, 2026 7:05 AM - StreetInsider Wolfe Research Starts Protagonist Therapeutics (PTGX) at Outperform May 21, 2026 5:32 AM - StreetInsider Form 4/A Protagonist Therapeutics For: May 12 Filed by: PATEL DINESH V PH D May 14, 2026 8:07 PM - SEC Filing Form 4 Protagonist Therapeutics For: May 12 Filed by: PATEL DINESH V PH D May 12, 2026 7:28 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: PATEL DINESH V PH D May 12, 2026 5:30 PM - SEC Filing Form SCHEDULE 13G Protagonist Therapeutics Filed by: STATE STREET CORP May 12, 2026 11:51 AM - SEC Filing Form 4 Protagonist Therapeutics For: May 07 Filed by: Giraudo Bryan May 11, 2026 8:26 PM - SEC Filing BMO Capital Reiterates Outperform Rating on Protagonist Therapeutics (PTGX) May 11, 2026 9:22 AM - StreetInsider Form 144 Protagonist Therapeutics Filed by: Giraudo Bryan May 8, 2026 4:23 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: Giraudo Bryan May 7, 2026 5:22 PM - SEC Filing Form 144 Protagonist Therapeutics Filed by: Giraudo Bryan May 7, 2026 4:49 PM - SEC Filing Protagonist Therapeutics (PTGX) PT Raised to $137 at Citizens May 6, 2026 4:28 AM - StreetInsider Protagonist Therapeutics (PTGX) Tops Q1 EPS by 54c May 5, 2026 5:24 PM - StreetInsider Form 10-Q Protagonist Therapeutics For: Mar 31 May 5, 2026 4:27 PM - SEC Filing Form 8-K Protagonist Therapeutics For: May 05 May 5, 2026 4:09 PM - SEC Filing Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update May 5, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G Protagonist Therapeutics Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 11:57 AM - SEC Filing Form SCHEDULE 13G Protagonist Therapeutics Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 29, 2026 2:43 PM - SEC Filing Form ARS Protagonist Therapeutics For: Dec 31 April 28, 2026 4:55 PM - SEC Filing Form DEFA14A Protagonist Therapeutics April 28, 2026 4:51 PM - SEC Filing Form DEF 14A Protagonist Therapeutics For: Jun 17 April 28, 2026 4:45 PM - SEC Filing Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration April 28, 2026 9:05 AM - StreetInsider Form 4 Protagonist Therapeutics For: Apr 23 Filed by: PATEL DINESH V PH D April 24, 2026 4:11 PM - SEC Filing Full Article List